Understanding the Zantac Recall: Why Was Ranitidine Taken Off the Market?
•
3 min read
In April 2020, the U.S. Food and Drug Administration (FDA) took the historic step of requesting the immediate market withdrawal of all prescription and over-the-counter (OTC) ranitidine products, commonly known by the brand name Zantac. This definitive action was prompted by growing evidence that the drug was contaminated with a probable human carcinogen called N-nitrosodimethylamine (NDMA).